Drug Shortage Report for VOLTAREN OPHTHA
Report ID | 130021 |
Drug Identification Number | 01940414 |
Brand name | VOLTAREN OPHTHA |
Common or Proper name | VOLTAREN 0.1% SOLN. 5 ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-12-14 |
Actual start date | 2020-12-14 |
Estimated end date | 2021-01-15 |
Actual end date | 2021-01-19 |
Shortage status | Resolved |
Updated date | 2021-01-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-12-10 | English | Compare |
v2 | 2020-12-10 | English | Compare |
v3 | 2020-12-10 | French | Compare |
v4 | 2020-12-15 | English | Compare |
v5 | 2020-12-21 | English | Compare |
v6 | 2020-12-21 | French | Compare |
v7 | 2021-01-12 | English | Compare |
v8 | 2021-01-12 | French | Compare |
v9 | 2021-01-19 | English | Compare |
v10 | 2021-01-19 | French | Compare |
v11 | 2021-01-20 | English | Compare |
Showing 1 to 11 of 11